Division of Child and Adolescent Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
Behav Res Ther. 2013 Oct;51(10):680-9. doi: 10.1016/j.brat.2013.07.003. Epub 2013 Jul 16.
To evaluate the feasibility, acceptability, and preliminary efficacy of a novel behavioral intervention for reducing symptoms of selective mutism and increasing functional speech.
A total of 21 children ages 4 to 8 with primary selective mutism were randomized to 24 weeks of Integrated Behavior Therapy for Selective Mutism (IBTSM) or a 12-week Waitlist control. Clinical outcomes were assessed using blind independent evaluators, parent-, and teacher-report, and an objective behavioral measure. Treatment recipients completed a three-month follow-up to assess durability of treatment gains.
Data indicated increased functional speaking behavior post-treatment as rated by parents and teachers, with a high rate of treatment responders as rated by blind independent evaluators (75%). Conversely, children in the Waitlist comparison group did not experience significant improvements in speaking behaviors. Children who received IBTSM also demonstrated significant improvements in number of words spoken at school compared to baseline, however, significant group differences did not emerge. Treatment recipients also experienced significant reductions in social anxiety per parent, but not teacher, report. Clinical gains were maintained over 3 month follow-up.
IBTSM appears to be a promising new intervention that is efficacious in increasing functional speaking behaviors, feasible, and acceptable to parents and teachers.
评估一种新的行为干预减少选择性缄默症症状和增加功能性言语的可行性、可接受性和初步疗效。
21 名年龄在 4 至 8 岁的原发性选择性缄默症儿童被随机分为 24 周的综合行为疗法治疗选择性缄默症(IBTSM)或 12 周的候补名单对照。使用盲法独立评估者、父母和教师报告以及客观行为测量评估临床结果。治疗接受者完成了三个月的随访,以评估治疗效果的持久性。
数据表明,治疗后父母和教师评定的功能性言语行为增加,盲法独立评估者评定的高比例治疗反应者(75%)。相比之下,候补名单对照组的儿童在说话行为方面没有显著改善。接受 IBTSM 的儿童在学校的说话次数也比基线有显著提高,但没有出现显著的组间差异。治疗接受者的社交焦虑也根据家长报告显著降低,但教师报告则没有。临床改善在 3 个月的随访中得到维持。
IBTSM 似乎是一种有前途的新干预措施,在增加功能性言语行为方面有效,对家长和教师来说是可行和可接受的。